Willett D E
Hassard, Bonnington, Rogers, and Huber, San Francisco.
Arch Pathol Lab Med. 1989 Mar;113(3):307-10.
Blood banks and transfusion services should anticipate that patients contracting transfusion-transmitted diseases will claim that these facilities have a duty to warn or notify patients of potential transfusion risks. Although physicians treating patients must secure informed consent by describing significant risks and possible alternatives, precedent does not support extending informed consent requirements to the hospital or blood bank. Nonetheless, efforts to find new sources of compensation may cause judges to develop new theories of liability. Blood bank and transfusion service medical directors, therefore, are advised to provide clinicians with information regarding current or emerging transfusion risks and alternatives such as autologous transfusion, urging communication to patients when informed consent is obtained.
血库和输血服务机构应预料到，感染输血传播疾病的患者会声称这些机构有责任向患者警示或告知潜在的输血风险。尽管治疗患者的医生必须通过描述重大风险和可能的替代方案来确保获得知情同意，但先例并不支持将知情同意要求扩展至医院或血库。尽管如此，寻求新赔偿来源的努力可能会促使法官形成新的责任理论。因此，建议血库和输血服务机构的医学主任向临床医生提供有关当前或新出现的输血风险以及诸如自体输血等替代方案的信息，并敦促在获得知情同意时与患者进行沟通。
